Clinical Trial Update: Repurposing Siponimod for Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating repurposing siponimod for Alzheimer's disease, with recruitment ongoing for Alzheimer's disease and related mild cognitive impairm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• MAYZENT (siponimod)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Alzheimer Disease, Mild Alzheimer Disease | Phase 2 | Status: RECRUITING